Hodges Capital Management’s Teladoc Health TDOC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q2
Sell
-11,601
Closed -$948K 236
2019
Q1
$948K Sell
11,601
-136,995
-92% -$8.36M 0.1% 132
2018
Q4
$8.04M Buy
148,596
+138,346
+1,350% +$8.47M 0.9% 38
2018
Q3
$885K Sell
10,250
-1,950
-16% -$139K 0.07% 145
2018
Q2
$708K Sell
12,200
-3,300
-21% -$161K 0.05% 162
2018
Q1
$625K Buy
15,500
+200
+1% +$7.55K 0.05% 170
2017
Q4
$533K Buy
+15,300
New +$508K 0.04% 179
2017
Q1
Sell
-223,000
Closed -$3.68M 297
2016
Q4
$3.68M Buy
223,000
+121,500
+120% +$2.06M 0.17% 105
2016
Q3
$1.86M Buy
+101,500
New +$1.78M 0.09% 129

Other funds holding TDOC

Hodges Capital Management's TDOC Position: Q2 2019 in Review

Hodges Capital Management sold out of Teladoc Health (TDOC) in Q2 2019, closing a stake of 11,601 shares — an estimated $948K sold.

Hodges Capital Management first reported a position in TDOC in Q3 2016 and held it in 8 quarters. The position peaked at $8.04M in Q4 2018. 371 funds tracked by Wall St. Rank hold TDOC as of Q2 2019.

  • Hodges Capital Management reported no remaining Teladoc Health position as of Q2 2019 after selling out during the quarter.
  • Hodges Capital Management sold 11,601 Teladoc Health shares in Q2 2019, an estimated $948K.
  • Hodges Capital Management first reported a position in Teladoc Health in Q3 2016 and held it in 8 quarters.
  • Hodges Capital Management's Teladoc Health position peaked at $8.04M in Q4 2018.
  • 371 funds tracked by Wall St. Rank held Teladoc Health as of Q2 2019.

Based on Hodges Capital Management's 13F filing for Q2 2019, filed 22 Aug 2019.